Gds Wealth Management Pfizer Inc Transaction History

Gds Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $42,537 - $48,846	-1,643 Reduced 14.3%	9,846 $273,000
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $4,990 - $6,482	-191 Reduced 1.64%	11,489 $330,000
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $50,317 - $58,815	-1,568 Reduced 11.84%	11,680 $387,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $26,909 - $31,133	-745 Reduced 5.32%	13,248 $485,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $296,921 - $386,548	-7,538 Reduced 35.01%	13,993 $570,000
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $213,843 - $279,149	-5,122 Reduced 19.22%	21,531 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $13,740 - $16,773	-314 Reduced 1.16%	26,653 $1.17 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $24,474 - $29,019	-526 Reduced 1.91%	26,967 $1.41 Million
Q1 2022 Aug 05, 2022	BUY	$45.75 - $56.69 $732 - $907	16 Added 0.06%	27,493 $1.43 Million
Q4 2021 Aug 05, 2022	BUY	$41.32 - $61.25 $1.14 Million - $1.68 Million	27,477 New	27,477 $1.62 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gds Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Gds Wealth Management with notifications on news.